India's first dengue vaccine approved India's drug regulatory authority has approved the Kydenga vaccine against dengue for use. The dengue vaccine has been approved in India. The vaccine named Kydenga, developed by a Japanese company against the dengue virus, has been approved for use in India. Developed by Japanese pharmaceutical company Takeda Pharmaceuticals , this vaccine has been approved by India's drug regulatory authority Central Drug Standards and Organization (CDACO). The Kydenga vaccine is said to provide protection against all four types of dengue virus serotypes 1, 2, 3 and 4 . Like the COVID-19 vaccine , it requires two doses. The second dose should be given three months after the first dose. This vaccine, which can be given to people aged 4 to 60 years, can also be given to those who have not had dengue. This vaccine, which is currently being produced in India, currently costs between Rs 6,000 and Rs 12,000 per dose . The price is expected to come down in ...
What kind of person is at risk of bone cancer? Sarcoma is a cancer caused by uncontrolled cell growth in muscles and bones. This cancer can occur in soft muscles, bones, fat, tissues, blood vessels, nerves and joints. This cancer cell develops rapidly in the soft cells that are mostly found in the bones. Initially, this cancer develops in 'connective tissue' (tissue connecting two organs). Then gradually other areas start spreading. This cancer then spreads to the lungs. This cancer is considered rare but very deadly. Because there are more than 70 types of this cancer. Out of which, two main types are soft tissue sarcoma and bone sarcoma. Sarcoma accounts for one percent of cancer in adult patients and 15 percent in children. There are different types of sarcoma including osteo sarcoma, angio sarcoma, chondro sarcoma, chondroma, fibro sarcoma, Ewing sarcoma, leiomyo sarcoma, lipo sarcoma, malignant, peripheral nerve. Of which osteosarcoma is the most common. How is sarcoma ca...